Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spectral Precise Image-Colon Cancer

NCT: NCT07620444 · NOT_YET_RECRUITING

NCT IDNCT07620444
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2026-12-31
SponsorPhilips Clinical & Medical Affairs Global (INDUSTRY)
First posted
Last updated

Brief Summary

This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.

Frequently Asked Questions

What is Spectral Precise Image-Colon Cancer?

Spectral Precise Image-Colon Cancer is a clinical trial registered under NCT07620444. Current status: NOT_YET_RECRUITING.

What is the status of NCT07620444?

The current status of NCT07620444 (Spectral Precise Image-Colon Cancer) is: NOT_YET_RECRUITING.

When did Spectral Precise Image-Colon Cancer start?

Spectral Precise Image-Colon Cancer started on 2026-06-01.

Related Devices

K201745Deep Learning Image Reconstruction for Gemstone Spectral ImagingGe Medical Systems, LLC K183202Deep Learning Image ReconstructionGe Medical Systems, LLC K193170Deep Learning Image ReconstructionGe Healthcare Japan Corporation K212067Deep Learning Image ReconstructionGe Healthcare Japan Corporation K213999Deep Learning Image ReconstructionGe Medical Systems, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑